Recruiting NA INTERVENTIONAL 2-arm NCT04409860

The Efficacy of Adjuvant Chemotherapy in Locally Advanced Cervical Cancer (CQGOG0102)

Randomized Controlled Trial of the Efficacy of Adjuvant Chemotherapy in Patients With Residual Lesions After Concurrent Radiochemotherapy for Locally Advanced Cervical Cancer

Sponsor: Chongqing University Cancer Hospital

Conditions Cervical Cancer

Interventions CCRT Paclitaxel, Cisplatin

Updated 6 times since 2020 Last updated: Apr 8, 2023 Started: May 26, 2020 Primary completion: Apr 30, 2024 Completion: Apr 30, 2029

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Cervical Cancer, this trial is actively recruiting participants. The trial is conducted by Chongqing University Cancer Hospital and has accumulated 6 data snapshots since 2020. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
May 2023 — Jul 2024 [monthly]

Recruiting NA
May 2022 — May 2023 [monthly]

Recruiting NA
Jan 2021 — May 2022 [monthly]

Recruiting NA

▶ Show 1 earlier version

Jul 2020 — Jan 2021 [monthly]

Recruiting NA

First recorded

May 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Chongqing University Cancer Hospital

Data source: Chongqing University Cancer Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Chongqing, China